AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $125.19
- 52-wk high
- $155.44
- High
- $128.13
- 52-wk low
- $23.30
- Low
- $123.75
- Prev close
- $125.52
- Mkt cap
- $8.03B
- Volume
- 901.9K
- Beta
- 2.22
- P/S
- 19.5x
- P/B
- 18.4x
- Profit margin
- -31.7%
- Op margin
- -30.6%
- ROE
- -29.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 12.0% below what analysts expected.
Earnings per share
-$0.50 expected
What the street expects next
EPS expected
-$0.02 to -$0.02
Revenue expected
9 analysts
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $99.0M | $103.7M | $110.7M | $118.4M |
| Cost of what it sold | $48.2M | $49.7M | $53.6M | $55.9M |
| Gross profit | $50.8M | $54.0M | $57.1M | $62.5M |
| What it spent | ||||
| Research and development | $17.0M | $17.1M | $19.7M | $18.0M |
| Sales and admin | $56.8M | $69.9M | $76.1M | $80.7M |
| Other operating costs | $7.0M | — | — | — |
| Total operating expenses | $80.8M | $86.9M | $95.8M | $98.7M |
| What was left | ||||
| Operating profit | -$29.9M | -$32.9M | -$38.7M | -$36.3M |
| Profit before tax | -$26.9M | -$30.3M | -$44.0M | -$34.7M |
| Tax | $256.0K | $253.0K | $43.0K | -$311.0K |
| Net profit | -$27.1M | -$30.5M | -$44.0M | -$35.1M |
| EBITDA | -$20.9M | -$26.7M | -$32.2M | -$28.0M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bearish
Tone of tracked coverage
BWS Financial initiates Twist Bioscience stock with sell rating By Investing.com
NeutralSep 9BWS Financial initiates Twist Bioscience stock with sell rating
BearishSep 9Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
Leans bullishSep 9Claim your share of the $17 million Twist Bioscience securities class action settlement
BearishSep 8Cathie Wood’s ARK sees major stock moves with Robinhood and Twist Bioscience By Investing.com
Leans bearishSep 5
Macro
10 macro signals shaping TWST right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results